Carleton Experts Available: Peptides
Peptides seem all the rage as a cure-all, even though legitimate concerns exist regarding ‘grey’ market peptides, primarily sold and distributed online. However, there are still many potential health benefits of prescribed therapeutic peptides that are worth exploring. Carleton experts are available to discuss related topics.
If you are interested in speaking with the experts below, please feel free to reach out to them directly. If you require other assistance, please email Steven Reid, Media Relations Officer, at steven.reid3@carleton.ca.
For other experts, please visit the Carleton Experts Database: https://experts.carleton.ca/.
Sarah Everts
Professor and CTV Chair in Digital Science Journalism at Carleton University
Email: Sarah.Everts@carleton.ca
Everts, a former protein chemist, has reported on science and technology for over a decade. Her research interests lie at the intersection of scientific innovation, policy and cultural anthropology. In other words, why are some of society’s most pressing science, health and environmental issues mired in a challenging combination of controversy, pseudoscience and legitimate uncertainty?
For more on Everts, visit: https://carleton.ca/sjc/profile/everts-sarah/
Ashkan Golshani
Professor, Department of Biology at Carleton University
Email: ashkan.golshani@carleton.ca
In addition to his academic work at Carleton, Golshani is the biochemist and CEO of Designed Biologics Inc., which designs custom peptides for biotech companies that use them to create new medications. He has been working on peptide design for more than 20 years. Golshani is available to discuss AI-guided peptide design, as well as peptides for therapeutic/diagnostic purposes.
For more on Golshani, visit: https://carleton.ca/biology/people/ashkan-golshani/
David Sabatino
Professor, Department of Chemistry at Carleton University
Email: david.sabatino@carleton.ca
Sabatino is available to share his insights on therapeutic peptides, the good, bad and in-between applications. His research interests span the areas of nucleic acid and peptide chemical biology to explore the influence of structural modification on the anti-cancer activity of these synthetic biological molecules for their applications in drug discovery.
For more about Sabatino, visit: https://experts.carleton.ca/david-sabatino
Media Contact
Steven Reid (he/him)
Media Relations Officer
Carleton University
613-265-6613
Steven.Reid3@carleton.ca
Looking for a Carleton expert?
Visit: https://experts.carleton.ca/
